Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Osteosarcoma × mifamurtide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Ifosfamide 10 Methotrexate 9 Doxorubicin 6 Magnetic Resonance Spectroscopy 5 Filgrastim 5 Etoposide 5 Cisplatin 5 Sirolimus 4 Leucovorin 4 temsirolimus 3 sargramostim 3 dinutuximab 3 cixutumumab 3 X-Rays 3 Specimen Handling 3 Radiotherapy 3 Phantoms, Imaging 3 Granulocyte-Macrophage Colony-Stimulating Factor 3 Gemcitabine 3 Dexrazoxane 3 samarium Sm-153 lexidronam 2 lenvatinib 2 glucarpidase 2 etoposide phosphate 2 Zoledronic Acid 2 Surveys and Questionnaires 2 Surgical Procedures, Operative 2 Radiotherapy, Image-Guided 2 Pemetrexed 2 Nuclear Medicine Department, Hospital 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02441309 2019-09-13

MEMOS

University of Oxford

Phase 2 Terminated

8 enrolled 17 charts

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡